APODDC
@apoddc
We’ll be hosting Clinical Trial Design webinars in 2023! Follow us to be kept up to date. 📊🧑🏻💻
You might like
📢 #Happy to share w/ #LCSM community! After 3+ years of work, we are pleased to share our #cost_effectiveness modelling for #lungcancer 🫁 #screening 🏥📸 in both #high-risk populations determined by both #smoking & #non-smoking risk factors e.g. family history for an entire…
Safety of tarlatamab with 6-8h outpatient vs 48-h inpatient monitoring during C1: DeLLphi-300 ph1 substudy in @ESMO_Open. Outpatient monitoring feasible, same CRS rate, most managed w/o hospitalization/ER visit. Anticipate&monitor AEs in educated pts is🔑. esmoopen.com/article/S2059-…
Newly published ESMO recommendations provide roadmap for the implementation of molecular tumour boards in clinical practice. Discover the key focus areas to optimise #PrecisionOncology Read via #ESMODailyReporter: ow.ly/mexL50VvtUM @BenWestphalen @Annals_Oncology
Wonderful crew of @myESMO #ESMORarecancer25 #YOCasesDiscussion session! Definitely not-so-young oncologists including #myself are also welcome. Great cases discussed and thanks everyone for contributing to lively discussions. @pawel_sobczuk @DrLizConnolly @Robertasanfili…
It's pleasure coauthoring this @Cancer_Cell commentary with 2 talented drug development fellows #gregoire marret and #mercedes herrera @pmcancercentre - "Turning the Kaleidoscope: Innovations shaping the future of clinical trials design" authors.elsevier.com/a/1kljp5TA51lC…
🔥 @JCO_ASCO 🆙 ✅LIBRETTO-001 final: Selpercatinib in RET Fusion–Positive Non–Small Cell Lung Cancer 🎯mOS 47.6 (pretreated pts), not reached (treatment-naïve) 👥 @GautschiOliver #LCSM @OncoAlert
Selpercatinib in RET Fusion–Positive Non–Small Cell Lung Cancer #NSCLC 🫁 : Final Safety and Efficacy, Including Overall Survival, From the LIBRETTO-001 Phase I/II Trial buff.ly/YlqitQJ This phase I/II study evaluating selpercatinib in RET fusion-positive non–small…
Delighted to share our review paper on ADCs in NSCLC with AGA is out! Very timely given the anticipated data readouts this year. Such an honour to be a part of this awesome team, special thanks to @g_mountzios and @JordiRemon for leading this 🙌🏻
Biomarker-selected or biomarker-agnostic ADCs for oncogene-addicted #NSCLC❓ 💡Just out in @myESMO #CancerTreatmentReviews a comprehensive overview on current landscape, challenges and perspectives Grateful to work with a global amazing team, including @stephanieplsaw…
It's ok at #CTOS2024 to drag me to your poster to pitch your science for Clinical Cancer Research, it the most inspiring thing i get to do!!
Phase 2 Study: Trametinib Treatment of Epithelioid Hemangioendothelioma. bit.ly/40pDRBc
Thanks @drkiwicj @drkiwikate @anmwongNZ @cameroncologist #DaisyMak (who needs to get on Twitter! 😆) & all my other 🇳🇿 #oncology friends @NzsOncology for your invitation & hospitality. Amazing talks & discussions throughout the conference. Perfect forum to build collaborations.…
What a privilege to have an academic of the quality of @herbloong speaking at @NzsOncology on precision oncology. Kia Ora Herbert!
Thank you superstar @herbloong for being a keynote speaker @NzsOncology Timely discussions on accessibility/ cost savings for #PrecisionOncology Need personalise a model for 🇳🇿 too! @apoddc @TeWhatuOra @cancer_agency
Thank you @jeanyvesblay for your excellent talk at the @cddf_eu - @EORTC workshop #RareCancers You last slides summarized it so well
Thanks @drdgoldstein for coming all the way from 🇮🇱 to 🇭🇰 to share insights and experiences in #pharmacoeconomics. Organised by #ProfVivianLee and colleagues of @cuhkpharmacy Very engaged workshop together with stakeholders from #academia, #industry, #patientsrepresentatives and…
📢Announcement: Join us at our 1st #APODDCForum2024 where we discuss about the Regulatory Harmonisation for Oncology Clinical Trials & Therapeutics Registration in the APAC Region📷 Sign up now via lnkd.in/gDPsHNib!📧 More details on our LinkedIn Page!
📢 T-28 days to our 6th @CUHKMedicine #CUHKSarcoma Masterclass in #hongkong 🇭🇰! We are looking forward to welcoming #international and #local faculties to our annual event. Congrats to 8 overseas attendees who have been #awarded #travelgrants to #present and #attend this year's…
Truly honored to have been invited to speak on EGFR-mut NSCLC at the National Cancer Center in Singapore by Daniel Tan and his incredible team. Grateful for the opportunity to share insights and collaborate on such an important topic @danieltanmd @SingHealthSG @pankajpanda86…
Congrats @jeanyvesblay & colleagues of #FrenchSarcomaGroup for completing study of #6vs3years of #adjuvant #imatinib 💊i n pts w/ #highrisk #GISTs. Presented at @myESMO @AACR #virtualplenary over last #2days with #specific discussions from #APAC #discussants as well!…
#ESMOVirtualPlenary: And straight after the first abstract session tomorrow (9/5), remain connected to discover more promising results on #GIST. 📢 A randomised study of 6 vs 3 years of adjuvant imatinib in pts w/ localised GIST at high risk of relapse. ow.ly/rKAa50Rza70…
Prof Jacky Lam sharing at the @CUHKMedicine Department of Clinical Oncology Academic Meeting on liquid biopsy for early cancer detection #oncology
Kicked off @ASCO #AsiaPacific #RegionalCouncil meeting in #Kuching #Sarawak 🇲🇾 w/ dedicated council members representing our region and #ASCOStaff. Happy to #vett & #deliver specific initiatives which will benefit #oncology landscape in our region. @DrRoselleDG @DrMLChua…
Kudos to the team! Has been part of this amazing team since the beginning in 2019, it’s very encouraging to see where it leads us now. Thankyou @ASCO APAC Regional Council, Pfizer, and Sarawak Gen Hospital team! Great leadership @DrMLChua ! @DrRoselleDG @herbloong @drkiwikate
United States Trends
- 1. #WWERaw 78.6K posts
- 2. Packers 52.1K posts
- 3. Packers 52.1K posts
- 4. Jordan Love 7,188 posts
- 5. John Cena 73.4K posts
- 6. Jalen 17.2K posts
- 7. #GoPackGo 5,393 posts
- 8. #RawOnNetflix 1,981 posts
- 9. Jenkins 3,318 posts
- 10. Kevin Patullo 1,035 posts
- 11. Grand Slam Champion 22.5K posts
- 12. Desmond Bane 1,862 posts
- 13. Matt LaFleur 1,395 posts
- 14. Lane Johnson 1,170 posts
- 15. #MondayNightFootball 1,156 posts
- 16. Green Bay 12.3K posts
- 17. Nikki Bella 3,075 posts
- 18. Cam Whitmore 1,464 posts
- 19. Jaelan Phillips 1,451 posts
- 20. #PHIvsGB 1,391 posts
You might like
-
Herbert Loong, MBBS, FASCO
@herbloong -
Ben Solomon
@bensolomon1 -
Sam Stevens
@SamuelXStevens -
Molly Li
@mollylisc -
Daniel Tan
@danieltanmd -
Melvin LK CHUA | FRCR, PhD, FASCO
@DrMLChua -
Thanyanan Baisamut (Reungwetwattana)
@reungwetwattana -
Roselle De Guzman
@DrRoselleDG -
Stephanie Saw
@stephanieplsaw -
pl
@pueyl -
NZSOncology
@NzsOncology -
Ching-Tso Chen
@robarroyce1
Something went wrong.
Something went wrong.